Sydney Lepkin
👤 SpeakerAppearances Over Time
Podcast Appearances
Its focus will include overdose reversal medicines, and it will not involve the Sacklers.
People buying Wagovi directly from Novo Nordisk will now be able to get it for around $350 a month.
Until the end of next March, the company will offer the first two months doses at around $200 a month.
That's down from about $500 a month.
And patients can get the same discount from Costco, GoodRx, Weight Watchers, and Rho, according to the company.
The lower price is only available to patients not using their health insurance.
Novo Nordisk's announcement follows the Trump administration's deals with Novo Nordisk and Eli Lilly earlier this month.
The deals included lower direct-to-consumer costs of the company's blockbuster obesity drugs.
But even the discounted prices will still be too high for many patients.
The number of adults taking GLP-1 drugs, which include Ozempic, Wegovy, Zephound, and Manjaro, is going up.
It went from 6% a year and a half ago to 12% now.
People are taking the drugs for chronic conditions like type 2 diabetes and heart disease, as well as for weight loss.
Here's Ashley Kurtzinger, a pollster at KFF.
Although most people taking these drugs say they have some insurance coverage for them, more than half say the drugs are difficult to afford.
KFF conducted the poll between October 27th and November 2nd.
Normally, companies can't advertise a drug to treat a condition it hasn't been FDA-approved to treat.